Personalized anti-cancer vaccine combining mRNA and immunotherapy tested in melanoma trial

Nature Medicine explores the latest translation and clinical research news, with a phase 3 trial from Merck and Moderna testing mRNA-4157 combined with pembrolizumab in melanoma. Nature Medicine explores the latest translation and clinical research news, with a phase 3 trial from Merck and Moderna t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature medicine 2023-10, Vol.29 (10), p.2379-2380
1. Verfasser:	Carvalho, Thiago
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedicine Cancer Research Cancer vaccines Immunotherapy Infectious Diseases Melanoma Metabolic Diseases Molecular Medicine mRNA Neurosciences News Pembrolizumab Translation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Nature Medicine explores the latest translation and clinical research news, with a phase 3 trial from Merck and Moderna testing mRNA-4157 combined with pembrolizumab in melanoma. Nature Medicine explores the latest translation and clinical research news, with a phase 3 trial from Merck and Moderna testing mRNA-4157 combined with pembrolizumab in melanoma. Image credit: Denis Pobytov / DigitalVision Vectors / Getty
ISSN:	1078-8956 1546-170X
DOI:	10.1038/d41591-023-00072-0